C
Incyte Corporation INCY
$83.80 -$0.95-1.12% NASDAQ
Recommendation
Prev Close
$83.80
Volume
1,576,610
Avg Vol (90D)
1,770,320
Market Cap
$16.36B
Dividend & Yield
--
52-Week Range
$53.56 - $88.66
P/E (TTM)
19.05
EPS (TTM)
$4.40
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Can Incyte Deliver on 447% EPS Forecasts and Pipeline Hype?
8/29/2025 - MarketBeat
Ambarella, Planet Labs, Box, Conagra, Incyte: Major Stock Moves!
10/11/2025 - TipRanks Financial Blog
Shikiar Asset Management Inc. Has $7.76 Million Stock Holdings in Incyte Corporation $INCY
10/11/2025 - MarketBeat
JPMorgan Chase & Co. Increases Incyte (NASDAQ:INCY) Price Target to $89.00
10/11/2025 - Ticker Report
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Incyte (NASDAQ:INCY) Stock
10/10/2025 - MarketBeat
Abbott to Report Q3 Earnings: Medical Devices Arm in Focus
10/10/2025 - Zacks Investment Research
What 14 Analyst Ratings Have To Say About Incyte
10/9/2025 - Benzinga
Strategic Deals Drive TEM Growth Amid Competition: Buy, Hold or Sell?
10/9/2025 - Zacks Investment Research
Incyte (NASDAQ:INCY) Given Hold (C+) Rating at Weiss Ratings
10/9/2025 - MarketBeat
TLRY Gears Up to Report Q1 Earnings: Cannabis Recovery in Focus
10/8/2025 - Zacks Investment Research
Incyte to Report Third Quarter Financial Results
10/8/2025 - GuruFocus
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
10/8/2025 - Zacks Investment Research
Incyte to Report Third Quarter Financial Results
10/8/2025 - Business Wire
Incyte (INCY): Assessing Valuation After Recent Share Price Momentum
10/8/2025 - Simply Wall St
Incyte downgraded to Perform from Outperform at Oppenheimer
10/8/2025 - TipRanks Financial Blog
Incyte just downgraded at Oppenheimer, here's why
10/8/2025 - The Fly
Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and Incyte (INCY)
10/8/2025 - TipRanks Financial Blog
HB Wealth Management LLC Makes New Investment in Incyte Corporation $INCY
10/8/2025 - MarketBeat
Will Incyte (INCY) Beat Estimates Again in Its Next Earnings Report?
10/7/2025 - Zacks Investment Research
Incyte Corporation (INCY) Appoints New Principal Financial Officer
10/6/2025 - GuruFocus
$17,000 per Month: How Sky-High Prescription Prices Take Toll On Patients
10/6/2025 - Zero Hedge
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
10/6/2025 - Zacks Investment Research
Legacy Trust Cuts Holdings in Incyte Corporation $INCY
10/5/2025 - MarketBeat
14,665 Shares in Incyte Corporation $INCY Acquired by Strid Group LLC
10/5/2025 - MarketBeat
LGT Fund Management Co Ltd. Buys Shares of 52,200 Incyte Corporation $INCY
10/4/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$4.58B
EBITDA (TTM)
$1.09B
EBIT (TTM)
$997.97M
Net Income (TTM)
$870.87M
Balance Sheet
Total Assets (Q)
$5.82B
Total Debt (Q)
$42.41M
Total Liabilities (Q)
$1.65B
Book Value Per Share (Q)
$21.49
Cash Flow
Cash from Operations (TTM)
$1.00B
Cash from Investing (TTM)
-$966.00K
Cash from Financing (TTM)
-$35.88M
Net Change in Cash (TTM)
$967.89M
Filings
Filing Date
Tuesday, July 29, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Oct 27 and 31 (est)
Price History
Loading...
Beta
0.44
7-Day Total Return
-2.87%
30-Day Total Return
-0.96%
60-Day Total Return
23.49%
90-Day Total Return
24.30%
Year to Date Total Return
20.52%
1-Year Total Return
26.74%
2-Year Total Return
47.12%
3-Year Total Return
24.61%
5-Year Total Return
-14.23%
52-week Low
Apr 09, 2025 - $53.56
52-week High
Oct 02, 2025 - $88.66
Valuation
Market Cap
$16.36B - Large Cap
Enterprise Value
$13.98B
Price/Sales (TTM)
3.63
Price/Book (Q)
3.90
Dividends and Shares
Shares Outstanding
198.74
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.incyte.com
Phone Number
302 498 6700
Address
1801 Augustine Cut-Off
Wilmington, DE 19803
Country
United States
Year Founded
1991
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan. The company offers... more
NASDAQ 10/10/2025 4:00PM Eastern Quotes delayed